Protalix gaucher diseases drug receives FDA CRL
Taliglucerase alfa is a plant-cell expressed form of the enzyme glucocerebrosidase (GCD). Taliglucerase is the first product for Protalix, and works by replacing an enzyme missing in people
Cellares and GenomeFrontier Therapeutics have announced a collaboration to assess automated manufacturing for the latter’s investigational CAR-T cell therapy, GF-CART01, on the Cell Shuttle platform.